Goldman Sachs used derivatives to help Exor build $2.8 billion Philips stake, filings show
By Toby Sterling, Pablo Mayo Cerqueiro and Andres Gonzalez AMSTERDAM
philips
US FDA identifies recall of Philips’ respiratory devices as most serious
(Reuters) – The U.S. Food and Drug Administration (FDA) on
Philips recalls some previously replaced ventilators -FDA statement
AMSTERDAM (Reuters) – Philips, which has been struggling with a
Paris prosecution office investigates Philips ventilators
PARIS (Reuters) – A department of the Paris prosecution office
Philips Subsidiary to Pay Over $24 Million for Alleged False Claims Caused by Respironics for Respiratory-Related Medical Equipment
WASHINGTON – Philips RS North America LLC, formerly known as
Philips North America Agrees to Pay $4.2 Million to Resolve Allegations of False Claims Act Violations
BOSTON – Philips North America LLC (Philips) has agreed to
Philips shareholders vote against executive compensation plan
AMSTERDAM – Philips shareholders voted against the company’s executive compensation
U.S. FDA asks Philips Respironics to notify patients about ventilator recall
– The U.S. Food and Drug Administration (FDA) asked Dutch